In this study, we provide evidence that exposure to sanggenol L can suppress cell growth in prostate cancer cells by triggering caspase-dependent and caspase-independent apoptosis, as well as cell cycle arrest, via the activation of tumor suppressor p53 and inhibition of PI3K/Akt/mTOR signaling. This evidence concerns the gene TP53 and prostate carcinoma.